Completed PHASE4 INTERVENTIONAL 2-arm NCT01231204

Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks

Sponsor: University of California, San Diego

Conditions Breast Cancer Mastectomy Paravertebral Catheter Insertion

Interventions Placebo (normal saline) Continuous Infusion Ropivicaine 0.4% Continuous Infusion

Updated 6 times since 2017 Last updated: Apr 7, 2016 Started: Oct 31, 2010 Primary completion: Nov 30, 2012 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Breast Cancer and Mastectomy, this trial is completed. The trial is conducted by University of California, San Diego and has accumulated 6 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of California, San Diego

Data source: University of California, San Diego

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• La Jolla, United States